Enuresis

Enuresis is involuntary urination at an age when bladder control is developmentally expected (generally from age five years onward).

It is classified as nocturnal (during sleep, by far the commoner presentation) or diurnal (during waking hours). It is also classified as primary (the child has never achieved a sustained period of dryness) or secondary (developing after at least six months of established dryness).

Secondary enuresis requires active consideration and exclusion of an underlying medical, psychological, or social precipitant.

Nocturnal enuresis is extremely common and in most affected children is a benign, self-limiting developmental variation. Management is supportive and non-punitive, centred on reassurance and structured behavioural intervention.

Classification and pathophysiology

• Primary nocturnal enuresis, the commonest presentation by a substantial margin, reflects a combination of factors. These are delayed maturation of bladder control and of the neurological signalling needed to wake to a full bladder, relatively reduced nocturnal antidiuretic hormone production (giving nocturnal urine output high for the child's functional bladder capacity), and, in some children, reduced functional bladder capacity.
• There is a strong genetic predisposition: enuresis is much more likely when one or both parents had a similar pattern in childhood.
• Secondary enuresis warrants careful search for an underlying cause. Causes include urinary tract infection, constipation (which directly impairs bladder function and capacity), and diabetes mellitus or diabetes insipidus (polyuria that overwhelms previously adequate bladder control).
• Psychological or social stressors also cause secondary enuresis, including family disruption, a new sibling or, in some cases, abuse. These need sensitive, full assessment of the child's psychosocial circumstances.
• Diurnal enuresis (daytime wetting) more often reflects a functional or, less commonly, structural bladder abnormality. Causes include overactive bladder, dysfunctional voiding, and less commonly a neurological or structural urological abnormality. It generally needs more active investigation than benign primary nocturnal enuresis alone.

• Nocturnal enuresis presents as involuntary urination during sleep, with variable frequency (most nights to occasional episodes), in a child old enough to be expected to be dry. The child characteristically sleeps through the episode, reflecting reduced nocturnal arousal and, frequently, relatively high nocturnal urine production.
• Associated daytime lower urinary tract symptoms (urgency, frequency, or daytime wetting) suggest combined bladder dysfunction. Enuresis without these symptoms is termed monosymptomatic, and with them non-monosymptomatic. The distinction informs both the likely mechanism and the targeted management.
• Assessment includes family history of enuresis, fluid intake patterns (particularly evening intake, including caffeinated beverages), bowel habit (constipation affects bladder function), and any psychosocial stressor or recent life change.
• Red flags warranting more urgent or specific evaluation are secondary enuresis, significant daytime symptoms alongside nocturnal enuresis, and symptoms suggesting urinary tract infection or diabetes (excessive thirst, weight loss, or a change in appetite).
• Any neurological symptom or sign is also a red flag, including abnormal gait or lower limb function, which could suggest a spinal cord abnormality affecting bladder innervation.
• Enuresis often has a significant impact on the child's self-esteem and social functioning, particularly sleepovers and other overnight stays. Parental frustration or inappropriate punitive responses may follow. Proactive, sensitive, supportive engagement with the child and family is needed.

• Diagnosis is clinical, based on involuntary urination in a child old enough to be expected to have bladder control.
• History covers the pattern, frequency, associated daytime symptoms, fluid intake, bowel habit and psychosocial context.
• Examination includes the abdomen for a palpable, loaded bowel suggesting constipation, and a brief, focused neurological assessment of the lower limbs and spine.
• Urinalysis is a standard part of initial assessment, screening for urinary tract infection or glycosuria (raising suspicion of diabetes mellitus). Further investigation, including blood glucose or renal tract imaging, is directed by concerns arising from the history and examination.
• A structured bladder diary over several days records fluid intake and voiding pattern (frequency, volume where feasible, urgency or daytime wetting episodes). It gives objective information that characterises the pattern and informs targeted management.
• Further urological investigation (renal and bladder ultrasound or, in selected cases, urodynamic studies) is generally reserved for significant, persistent daytime symptoms, secondary enuresis without a clear explanation, or other red flags. It is not routinely needed in isolated primary nocturnal enuresis without concerning features.

• Reassurance and psychoeducation are the foundation of management for every presentation. Emphasise that primary nocturnal enuresis is common, benign and typically self-resolving.
• Advise the family explicitly to avoid punitive or shaming responses to wetting. They are ineffective and counterproductive, worsening distress and self-esteem without improving the condition.
• Initial supportive measures include regular daytime voiding, including before bedtime. Encourage adequate daytime fluid intake while moderating fluids, particularly caffeinated beverages, in the hours before bedtime.
• Treat any identified constipation, given its direct impact on bladder function. Use positive reinforcement for dry nights, with a reward system based on achievement rather than punishment for wet nights.
• An enuresis alarm detects moisture and wakes the child at the onset of urination, supporting gradual conditioned arousal to bladder fullness. It is the first-line, evidence-based active treatment for children with sufficiently frequent enuresis.
• The alarm needs sustained, consistent use, commonly several weeks to a few months. It addresses the arousal mechanism directly and generally gives more durable improvement than pharmacological treatment alone.
• Desmopressin, a synthetic antidiuretic hormone analogue given orally at bedtime, is an effective pharmacological option. It reduces nocturnal urine production and so the likelihood of exceeding bladder capacity overnight. It suits short-term use (a sleepover or school trip) or as an alternative or adjunct to the alarm.
• Restrict evening fluid intake when using desmopressin, because of the risk of dilutional hyponatraemia if fluids are not restricted while the drug is active.
• In secondary enuresis, treat the cause: confirmed urinary tract infection, constipation, or support and intervention for an identified psychosocial stressor, alongside general supportive measures.
• Diurnal enuresis and non-monosymptomatic nocturnal enuresis (with significant daytime symptoms) need a more structured approach to the underlying bladder dysfunction. The principles are broadly those under overactive bladder and urgency urinary incontinence, adapted to children.
• Follow up regularly to reassess progress and adjust management according to response. Maintain a positive, non-punitive, reassuring approach throughout.